GCM
BSX icon

Grisanti Capital Management’s Boston Scientific BSX Stock Holding History

Grisanti Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$7.33M Buy
224,746
+27,360
+14% +$1.07M 4.51% 9
2019
Q4 		$8.93M Sell
197,386
-540
-0.3% -$22.6K 4.31% 5
2019
Q3 		$8.05M Sell
197,926
-1,595
-0.8% -$67.6K 4.4% 7
2019
Q2 		$8.57M Buy
+199,521
New +$7.67M 4.68% 6

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Grisanti Capital Management's BSX Position: Q1 2020 in Review

Grisanti Capital Management increased its Boston Scientific (BSX) stake by 14% in Q1 2020, buying an estimated $1.07M and bringing the position to 224,746 shares worth $7.33M. The position accounts for 4.51% of the portfolio, ranked #9.

Grisanti Capital Management first reported a position in BSX in Q2 2019 and has held it in 4 quarters since. The position peaked at $8.93M in Q4 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Grisanti Capital Management held 224,746 shares of Boston Scientific worth $7.33M as of Q1 2020.
  • Grisanti Capital Management bought 27,360 Boston Scientific shares in Q1 2020, an estimated $1.07M.
  • Boston Scientific made up 4.51% of Grisanti Capital Management's portfolio in Q1 2020, its #9 holding.
  • Grisanti Capital Management first reported a position in Boston Scientific in Q2 2019 and has held it in 4 quarters since.
  • Grisanti Capital Management's Boston Scientific position peaked at $8.93M in Q4 2019.
  • 800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Grisanti Capital Management's 13F filing for Q1 2020, filed 6 May 2020.